Tandem Diabetes Care (TNDM) Other financing activities (2015 - 2024)

Tandem Diabetes Care's Other financing activities history runs 9 years deep, the most recent figure standing at $183000.0 for Q1 2024.

• Quarterly Other financing activities changed N/A year-over-year to $183000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $183000.0 (up 357.75% YoY) and the FY2024 annual result came in at $183000.0, up 357.75% from the prior year.
• Other financing activities was $183000.0 for Q1 2024 at Tandem Diabetes Care, up from -$71000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $2.0 million in Q2 2020 and bottomed at -$2.9 million in Q4 2020.
• A 5-year average of -$40000.0 and a median of $41500.0 in 2022 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2021 — Other financing activities soared 6157.14% — and 2022, when it tumbled 96.35%.
• Tandem Diabetes Care's Other financing activities stood at -$2.9 million in 2020, then surged by 79.8% to -$593000.0 in 2021, then fell by 13.83% to -$675000.0 in 2022, then surged by 89.48% to -$71000.0 in 2023, then jumped by 357.75% to $183000.0 in 2024.
• Business Quant data shows TNDM's Other financing activities at $183000.0 in Q1 2024, -$71000.0 in Q3 2023, and -$675000.0 in Q4 2022.